Andrews to leave IMB for angel role
23 July, 2002 by Pete YoungOne of the commanding figures on Queensland's life science scene, Prof Peter Andrews, is resigning as co-head of the state's flagship biotech research centre, the Institute for Molecular Bioscience.
$50m boost for Australian proteomics research
23 July, 2002 by Pete YoungAustralian proteomics research will receive a $50 million boost, thanks to a five-year program now being negotiated by three universities, a private company and the Australian Proteome Analysis Facility (APAF).
Proteomics facility opens at Bio21
18 July, 2002 by Tanya HollisVictorian Innovation Minister John Brumby officially opened a $12 million proteomics facility within the Bio21 precinct at Parkville today.
Supercomputers to the rescue
15 July, 2002 by Pete YoungBio-researchers are burning through about one-quarter of the total computational cycles at some of Australia's largest computing centres.
Aust-US biosoftware alliance touted
12 July, 2002 by Pete YoungTop-ranked computational biologists in Australia and the US are looking at joining forces to produce better software for bioscience researchers.
Autogen's 'beacon' gene wins patent protection
11 July, 2002 by Tanya HollisA gene implicated in conditions including obesity, diabetes and energy imbalance has gained Australian patent protection four years after its initial discovery.
Bioinformatics course kicks off in Qld
11 July, 2002 by Pete YoungAustralia's most ambitious attempt at bringing computer scientists and bioscientists together for bioinformatics training was launched this week in Queensland.
Starpharma finalises US nanotech set-up
10 July, 2002 by Tanya HollisAustralia's place in the futuristic world of nanotechnology has been further cemented with the set up of Dendrimer Nanotechnologies (DNT) now complete.
Bionomics to file international patent on genes
08 July, 2002 by Tanya HollisGene discovery group Bionomics plans to lodge an international patent covering almost 150 gene variants related to diseases including Alzheimer's, depression, epilepsy and Parkinson's.
ANGIS cheered after long-awaited cash injection
05 July, 2002 by Pete YoungThe Australian National Genomic Information Service (ANGIS) is in hiring mode, thanks to a small injection of fresh funds.
Vision moves to calm punters after biotech buy
05 July, 2002 by Tanya HollisVision Systems has moved to calm jittery investors following last week's $94 million purchase of UK biochemical manufacturer Novocastra Laboratories.
IBM's life science focus
04 July, 2002 by Iain ScottOn a recent visit to Sydney, IBM Life Sciences chief Caroline Kovac outlined her views on bio-IT, the life sciences and Australia's potential.
United we crunch
03 July, 2002 by Lafe LowExamining more than 3 billion molecules to determine which ones might treat a particular disease sounds like a lifetime's work, but the Anthrax Research Project (ARP) wrapped up just such a massive screening in 24 days. Of the nearly 3.6 billion molecules analysed, the project identified more than 376,000 as candidates for treating the anthrax bacterium, which would render it ineffective as a weapon.
3-D display puts images in the round
03 July, 2002 by Staff WritersLike something out of the movie Star Wars, start-up Actuality Systems this week uncloaked a 3-D computer display capable of turning flat computer-generated images into what look like solid objects.
AusBiotech seminar teaches biotechs how to play with the 'big boys'
03 July, 2002 by Melissa TrudingerA solid commercialisation plan during product development was one of the key messages from speakers at a recent AusBiotech seminar.
